Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic.
Kathryn HawrotLawrence N ShulmanIra J BleiweissElizabeth J WilkieZachary A K FroschRachel C JankowitzAmy I LaughlinPublished in: JCO oncology practice (2021)
TTI was maintained among patients diagnosed and treated for breast cancer during the COVID-19 pandemic at a single large academic center. There was a decrease in patient volume, specifically in patients with in situ disease and a shift in initial therapy toward the use of preoperative hormonal therapy.